Volume 19, Number 1—January 2013
Dispatch
Klebsiella pneumoniae Antimicrobial Drug Resistance, United States, 1998–2010
Table 2
Klebsiella pneumoniae antimicrobial drug resistance rates, United States, 2010*
Source, no. samples | AMK | GEN | TOB | TZP | ATM | IPM | CAZ | CRO | CPM | TMP/SXT | CIP | TET |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All, 187,359 | 4.5 | 9.2 | 13.8 | 12.7 | 22.2 | 4.3 | 17.2 | 12.1 | 7.7 | 19.3 | 16.8 | 16.7 |
Blood, 20,185 | 4.2 | 10.6 | 14.9 | 15 | 23.6 | 5.9 | 19.2 | 13.4 | 7.1 | 21.3 | 18.9 | 17.1 |
Urine, 112,567 | 4.1 | 7.8 | 12.4 | 10.6 | 21 | 3.8 | 15.1 | 10.9 | 7.1 | 18.3 | 15.1 | 17.3 |
Wound, 22,225 | 4.5 | 10.1 | 14.4 | 14.7 | 20.9 | 5 | 17.5 | 12.2 | 8.3 | 19.5 | 16.8 | 16.4 |
Respiratory, 32,382 | 5.8 | 11.1 | 15.8 | 16.4 | 24.5 | 4.7 | 21.3 | 15.5 | 9.9 | 20.2 | 20 | 15.5 |
*AMK, amikacin; GEN, gentamicin; TOB, tobramycin; TZP, piperacillin/tazobactam; ATM, aztreonam; IPM, imipenem; CAZ, ceftazidime; CRO, ceftriaxone; CPM, cefepime; TMP/SXT, trimethoprim/sulfamethoxazole; CIP, ciprofloxacin; TET, tetracycline.